Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
International Journal of Stroke : Official Journal of the International Stroke Society|April 5, 2019
A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III)Wendy C Ziai, Nichol McBee, Karen Lane, et al.
Cell Reports. Medicine|May 3, 2023
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trialTulika Ranjan, Soma Sengupta, Michael J Glantz, et al.
Neurosurgery|March 21, 2019
Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) ProcedureIssam A Awad, Sean P Polster, Julián Carrión-Penagos, et al.
Future Oncology (London, England)|December 7, 2023
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patientsIan Y Lee, Simon Hanft, Michael Schulder, et al.
Neurosurgery|January 21, 2021
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH TrialsSean P Polster, Julián Carrión-Penagos, Seán B Lyne, et al.
Science Immunology|April 23, 2021
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhageMichael H Askenase, Brittany A Goods, Hannah E Beatty, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Pageof 15